View Clinical Trial (Medical Research Study)
Fibromyalgia Acupuncture Study - NCT00882271-90604(Clinical Trial 285434)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Whittier |
|
State:
|
|
CA |
| Zip Code: |
|
90604 |
| Conditions: |
|
Fibromyalgia |
| Purpose: |
|
The acupuncture treatment in this study is particularly aimed at reducing the pain and other
negative health events such as emotional trauma and disability associated with Fibromyalgia,
while improving the quality of life and promoting general health.
|
| Study summary: |
|
It is hypothesized that acupuncture treatment will be effective in reducing pain and
improving lower body strength and overall functionality more than the sham acupuncture
treatment in people with Fibromyalgia (FM). The purpose of this study is to compare the
efficacy of acupuncture with simulated acupuncture in patients with FM using a randomized
controlled design. More specifically, the objectives of this study are to determine if
acupuncture can (1) reduce pain, (2) improve lower body strength, and (3) improve overall
functionality. |
| Criteria: |
|
Inclusion Criteria:
1. Participants must be 18 years or older and can be of either sex.
2. A confirmed diagnosis of FM (pain for more than three months) will be required to
participate in the study. If they do not have a diagnosis the study clinician or
research assistant will examine them and determine their eligibility.
3. All participants must be willing to provide a written informed consent prior to
participation and should not have undergone acupuncture treatment in the past.
Exclusion Criteria:
1. Acupuncture treatment in the past five years.
2. Unwilling to sign informed consent.
3. Less than a score of 40 on the Fibromyalgia Impact Questionnaire,
4. Involvement in any litigation currently or in the past,
5. Simultaneous infection with HIV/Hepatitis B virus.
6. Severe depression (Beck depression score >21),
7. History of substance abuse or dependence within the past year, excluding nicotine and
caffeine.
8. Serious or unstable cardiovascular, hepatic, renal, respiratory, or hematologic
illness, symptomatic peripheral vascular disease, or other medical conditions
(including unstable hypertension, hypo or hyperthyroidism, or psychological
conditions that in the opinion of the investigators would compromise participation or
be likely to lead to an adverse response, including injuries or hospitalization,
during the course of the study. We will get the information from the health/activity
questionnaire.
9. Have any DSM-IV Axis (major depression, addiction, anxiety) disorder which, in the
judgment of the investigators, would interfere with compliance with the study
protocol. |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
February 17, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|